The largest purchase of all time was on 2023-06-30 and amounted to 800000 shares of MoonLake Immunotherapeutics for $40M.
The largest sale of all time was on 2021-07-26 and amounted to 200000 shares of Erasca, Inc. for $3.75M.
No biography is available at this moment.
| 2023-10-05 | MoonLake Immunotherapeutics MLTX | 10 percent owner | 58,839 0.1027% | $59.90 | $3.52M | -24.48% | ||
| 2023-10-04 | MoonLake Immunotherapeutics MLTX | 10 percent owner | 67,814 0.1132% | $57.32 | $3.89M | -18.08% | ||
| 2023-10-03 | MoonLake Immunotherapeutics MLTX | 10 percent owner | 150,487 0.251% | $57.25 | $8.62M | -18.44% | ||
| 2023-10-02 | MoonLake Immunotherapeutics MLTX | 10 percent owner | 74,911 0.1252% | $57.37 | $4.3M | -18.03% | ||
| 2023-06-30 | MoonLake Immunotherapeutics MLTX | 10 percent owner | 800,000 1.1653% | $50.00 | $40M | +2.13% | ||
| 2023-06-26 | MoonLake Immunotherapeutics MLTX | 10 percent owner | 450,000 0.5982% | $45.63 | $20.54M | +13.22% | ||
| 2023-03-30 | Biomea Fusion, Inc. BMEA | 400,000 1.2695% | $30.00 | $12M | -47.04% | |||
| 2022-12-13 | Erasca, Inc. ERAS | director | 307,692 0.3325% | $6.50 | $2M | -44.42% | ||
| 2022-04-05 | MoonLake Immunotherapeutics MLTX | 2.85M 0.8303% | $10.00 | $28.5M | -37.81% | |||
| 2021-08-10 | Erasca, Inc. ERAS | director | 200,000 0.2202% | $22.10 | $4.42M | -41.38% | ||
| 2021-07-26 | Sale | Erasca, Inc. ERAS | director | 200,000 0.2009% | $18.77 | $3.75M | -35.23% | |
| 2021-07-20 | Erasca, Inc. ERAS | director | 950,000 0.7974% | $16.00 | $15.2M | -35.39% | ||
| 2021-04-20 | Biomea Fusion, Inc. BMEA | director | 900,000 3.6217% | $17.00 | $15.3M | -33% | ||
| 2020-10-22 | MoonLake Immunotherapeutics MLTX | CEO and Chairman | 430,000 0.1253% | $10.00 | $4.3M | -5.37% |